Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4275 USD | +2.52% | -7.87% | -23.66% |
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 60.66M |
---|---|---|---|---|---|
Net income 2021 | -23M | Net income 2022 | -15M | EV / Sales 2021 | - |
Net cash position 2021 | 42.19M | Net cash position 2022 | 17.76M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.01
x | P/E ratio 2022 |
-3.95
x | Employees | 9 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 29.71% |
Latest transcript on Tiziana Life Sciences Ltd
1 day | +10.22% | ||
1 week | -0.95% | ||
Current month | -4.37% | ||
1 month | -7.19% | ||
3 months | -19.21% | ||
6 months | -31.48% | ||
Current year | -17.93% |
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 20-06-30 |
Willy Simon
BRD | Director/Board Member | 72 | 15-10-31 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 98-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.4275 | +2.52% | 17 917 |
24-03-27 | 0.417 | -2.11% | 64,900 |
24-03-26 | 0.426 | -5.96% | 73,939 |
24-03-25 | 0.453 | -2.58% | 79,854 |
24-03-22 | 0.465 | +0.22% | 19,443 |
Delayed Quote Nasdaq, March 28, 2024 at 09:41 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.93% | 41.83M | |
+8.21% | 45.97B | |
+53.63% | 43.93B | |
+10.00% | 42.34B | |
-8.59% | 28.27B | |
+16.14% | 27.18B | |
-19.77% | 19.44B | |
+13.72% | 13.83B | |
+31.83% | 12.4B | |
+9.60% | 11.45B |